Top Markets
#1 Black Phoenix Black Phoenix +199.93%
#2 Islamic Coin Islamic Coin +158.02%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.45%
#5 Akedo Akedo +35.05%
#6 BasedHype BasedHype +32.54%
#7 Acurast Acurast +26.15%
#8 Cryptopia Cryptopia +21.67%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +17.60%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Clasificación en acciones #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Precio por acción
$0.0005
Última sincronización: 2026-08-11
Capitalización bursátil
$16.73K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio ARYx Therapeutics, Inc. (ARYX)

Categoría

Healthcare
Precio ARYX con Capital del mercado a B
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
ARYX
$0.0005
Capitalización de mercado de ARYx Therapeutics, Inc.(ARYX)
Capitalización bursátil: $16.73K
A fecha de August 2026, ARYx Therapeutics, Inc. tiene una capitalización de mercado de $16.73K. Esto convierte a ARYx Therapeutics, Inc. en la 41544th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de ARYx Therapeutics, Inc. desde 2007 hasta 2026
ARYX en comparación con los más populares 5 títulos stocks
Precio por ARYX Activo B Capital del mercado en B Resultados
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$160,880 $16.73K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,175,957,463.80%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$132,191 $16.73K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,438,295,302.18%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$124,331 $16.73K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +24,866,232,636.13%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$109,477 $16.73K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +21,895,408,644.25%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$86,403.35 $16.73K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,280,669,288.56%